Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 12,000 shares at $10.28 ($123K) on 2023-06-20, disclosed to the SEC on 2023-06-22.
Scheduled sale ($123k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.28 | 6,000 | $62K | 50.0% |
| 2 | $10.28 | 6,000 | $62K | 50.0% |
| Total | $10.28 avg | 12,000 | $123K | 100% |
| Filing → |
| ACRS | SELL | 2023-03-03 | $588K | — | Filing → |
| ACRS | SELL | 2023-02-17 | $65K | — | Filing → |
| ACRS | SELL | 2022-12-16 | $79K | — | Filing → |